Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Ajinomoto Bio-Pharma ServicesAjinomoto Bio-Pharma Services
VS
Hikma PharmaceuticalsHikma Pharmaceuticals
Ajinomoto Bio-Pharma Services

Ajinomoto Bio-Pharma Services

11040 Roselle St, San Diego, California, 92121, US

Last Update: 12/12/2025

View Profile
Between 750 and 799
http://www.ajibio-pharma.com
757/1000Fair

Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, United States, Japan, and India providing comprehensive development, cGMP manufacturing, and aseptic fill finish services for small and large m...

NAICS:325
NAICS Definition:N/A
Employees:788
Subsidiaries:13
12-month incidents
0
Known data breaches
0
Attack type number
0
Hikma Pharmaceuticals

Hikma Pharmaceuticals

1 New Burlington Place, London, W1S 2HR, GB

Last Update: 03/04/2026

View Profile
Between 750 and 799
http://www.hikma.com
767/1000Fair

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospita...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:10,252
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Ajinomoto Bio-Pharma Services

Ajinomoto Bio-Pharma Services

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Hikma Pharmaceuticals

Hikma Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Ajinomoto Bio-Pharma Services in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Hikma Pharmaceuticals in 2026.

Incidents

Incident History - Ajinomoto Bio-Pharma Services (X = Date, Y = Severity)

Ajinomoto Bio-Pharma Services cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Hikma Pharmaceuticals (X = Date, Y = Severity)

Hikma Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Ajinomoto Bio-Pharma Services

Ajinomoto Bio-Pharma Services

Incidents
No explicit notable incidents reported.
Hikma Pharmaceuticals

Hikma Pharmaceuticals

Incidents
No explicit notable incidents reported.

FAQ

Between Ajinomoto Bio-Pharma Services company and Hikma Pharmaceuticals company, which one has the best AI Cybersecurity Score ?
Between Ajinomoto Bio-Pharma Services company and Hikma Pharmaceuticals company, which one has experienced more cyber incidents in the past ?
Between Ajinomoto Bio-Pharma Services company and Hikma Pharmaceuticals company, which one has experienced more cyber incidents this year ?
Between Ajinomoto Bio-Pharma Services company and Hikma Pharmaceuticals company, which one has experienced at least one ransomware attack ?
Between Ajinomoto Bio-Pharma Services company and Hikma Pharmaceuticals company, which one has experienced at least one data breach ?
Between Ajinomoto Bio-Pharma Services company and Hikma Pharmaceuticals company, which one has experienced at least one targeted cyberattack ?
Between Ajinomoto Bio-Pharma Services company and Hikma Pharmaceuticals company, which one has experienced at least one vulnerability ?
Between Ajinomoto Bio-Pharma Services company and Hikma Pharmaceuticals company, which one holds the most compliance certifications ?
Between Ajinomoto Bio-Pharma Services company and Hikma Pharmaceuticals company, which one holds the fewest compliance certifications ?
Between Ajinomoto Bio-Pharma Services company and Hikma Pharmaceuticals company, which one has the most subsidiaries ?
Between Ajinomoto Bio-Pharma Services company and Hikma Pharmaceuticals company, which one has the largest number of employees ?
Between Ajinomoto Bio-Pharma Services and Hikma Pharmaceuticals, which company holds both SOC 2 Type 1 certifications ?
Between Ajinomoto Bio-Pharma Services and Hikma Pharmaceuticals, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Ajinomoto Bio-Pharma Services or Hikma Pharmaceuticals ?
Which company is PCI DSS compliant - Ajinomoto Bio-Pharma Services or Hikma Pharmaceuticals ?
Between Ajinomoto Bio-Pharma Services and Hikma Pharmaceuticals, which company complies with HIPAA regulations for healthcare data ?
Between Ajinomoto Bio-Pharma Services and Hikma Pharmaceuticals, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-59723
SUMMARY

Cline is an autonomous coding agent as an SDK, IDE extension, or CLI assistant. Prior to 3.0.30, the Cline Hub dashboard server launched by the cline dashboard command accepts WebSocket connections on the /browser endpoint without validating the Origin header, and when ROOM_SECRET is unset for local 127.0.0.1 binds, isAuthorizedBrowserRequest() allows attacker-controlled websites to send desktopCommand frames that read workspace state, mutate MCP and provider settings, and trigger command execution when a provider or model is configured. This issue is fixed in version 3.0.30.

PUBLISHED
Date2026-07-08
UPDATED
Date2026-07-08
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:A/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:H
IMPACT SCORE
6
EXPLOITABILITY
2.1
CVE-2026-54784
SUMMARY

CoreWCF is a port of the service side of Windows Communication Foundation (WCF) to .NET Core. In version 1.9.0, CoreWCF SPNEGO SecurityContextToken negotiation can expose the proof key recovered from the RSTR when TransportWithMessageCredential with Windows client credentials and session establishment are used, allowing an observer to impersonate the authenticated Windows principal and decrypt or forge WS-SecureConversation traffic. This issue is fixed in version 1.9.1.

PUBLISHED
Date2026-07-08
UPDATED
Date2026-07-08
RISK INFORMATION (Score: 7.4)
CVSS3
Base Score: 7.4
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N
IMPACT SCORE
5.2
EXPLOITABILITY
2.2
CVE-2026-54783
SUMMARY

CoreWCF is a port of the service side of Windows Communication Foundation (WCF) to .NET Core. Prior to 1.8.1 and 1.9.1, CoreWCF WS-Security endorsing and supporting signature verification does not ensure the selected ds:Signature covers the expected Security header target, allowing an attacker with one captured signed SOAP envelope to replay arbitrary service operations as the victim principal. This issue is fixed in versions 1.8.1 and 1.9.1.

PUBLISHED
Date2026-07-08
UPDATED
Date2026-07-08
RISK INFORMATION (Score: 7.4)
CVSS3
Base Score: 7.4
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N
IMPACT SCORE
5.2
EXPLOITABILITY
2.2
CVE-2026-54782
SUMMARY

CoreWCF is a port of the service side of Windows Communication Foundation (WCF) to .NET Core. Prior to 1.8.1 and 1.9.1, CoreWCF SAML 1.1 and SAML 2.0 token validation does not correctly resolve the issuer signing key or require signed tokens when IdentityConfiguration is used with federated bindings, allowing an unauthenticated remote attacker to impersonate any principal the trusted STS could issue. This issue is fixed in versions 1.8.1 and 1.9.1.

PUBLISHED
Date2026-07-08
UPDATED
Date2026-07-08
RISK INFORMATION (Score: 10)
CVSS3
Base Score: 10.0
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:N
IMPACT SCORE
5.8
EXPLOITABILITY
3.9
CVE-2026-54781
SUMMARY

CoreWCF is a port of the service side of Windows Communication Foundation (WCF) to .NET Core. Prior to 1.8.1 and 1.9.1, CoreWCF SAML token validation does not enforce SubjectConfirmation method URIs or holder-of-key proof keys in SamlSecurityTokenHandler, allowing holder-of-key downgrade or custom confirmation method assertions to authenticate a subject without proving authority over the assertion. This issue is fixed in versions 1.8.1 and 1.9.1.

PUBLISHED
Date2026-07-08
UPDATED
Date2026-07-08
RISK INFORMATION (Score: 7.4)
CVSS3
Base Score: 7.4
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N
IMPACT SCORE
5.2
EXPLOITABILITY
2.2